Cargando…
Nature-inspired nanocarriers for improving drug therapy of atherosclerosis
Atherosclerosis (AS) has emerged as one of the prevalent arterial vascular diseases characterized by plaque and inflammation, primarily causing disability and mortality globally. Drug therapy remains the main treatment for AS. However, a series of obstacles hinder effective drug delivery. Nature, fr...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460486/ https://www.ncbi.nlm.nih.gov/pubmed/37641591 http://dx.doi.org/10.1093/rb/rbad069 |
_version_ | 1785097654790782976 |
---|---|
author | Ji, Weihong Zhang, Yuanxing Deng, Yuanru Li, Changyong Kankala, Ranjith Kumar Chen, Aizheng |
author_facet | Ji, Weihong Zhang, Yuanxing Deng, Yuanru Li, Changyong Kankala, Ranjith Kumar Chen, Aizheng |
author_sort | Ji, Weihong |
collection | PubMed |
description | Atherosclerosis (AS) has emerged as one of the prevalent arterial vascular diseases characterized by plaque and inflammation, primarily causing disability and mortality globally. Drug therapy remains the main treatment for AS. However, a series of obstacles hinder effective drug delivery. Nature, from natural micro-/nano-structural biological particles like natural cells and extracellular vesicles to the distinctions between the normal and pathological microenvironment, offers compelling solutions for efficient drug delivery. Nature-inspired nanocarriers of synthetic stimulus-responsive materials and natural components, such as lipids, proteins and membrane structures, have emerged as promising candidates for fulfilling drug delivery needs. These nanocarriers offer several advantages, including prolonged blood circulation, targeted plaque delivery, targeted specific cells delivery and controlled drug release at the action site. In this review, we discuss the nature-inspired nanocarriers which leverage the natural properties of cells or the microenvironment to improve atherosclerotic drug therapy. Finally, we provide an overview of the challenges and opportunities of applying these innovative nature-inspired nanocarriers. |
format | Online Article Text |
id | pubmed-10460486 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-104604862023-08-28 Nature-inspired nanocarriers for improving drug therapy of atherosclerosis Ji, Weihong Zhang, Yuanxing Deng, Yuanru Li, Changyong Kankala, Ranjith Kumar Chen, Aizheng Regen Biomater Review Atherosclerosis (AS) has emerged as one of the prevalent arterial vascular diseases characterized by plaque and inflammation, primarily causing disability and mortality globally. Drug therapy remains the main treatment for AS. However, a series of obstacles hinder effective drug delivery. Nature, from natural micro-/nano-structural biological particles like natural cells and extracellular vesicles to the distinctions between the normal and pathological microenvironment, offers compelling solutions for efficient drug delivery. Nature-inspired nanocarriers of synthetic stimulus-responsive materials and natural components, such as lipids, proteins and membrane structures, have emerged as promising candidates for fulfilling drug delivery needs. These nanocarriers offer several advantages, including prolonged blood circulation, targeted plaque delivery, targeted specific cells delivery and controlled drug release at the action site. In this review, we discuss the nature-inspired nanocarriers which leverage the natural properties of cells or the microenvironment to improve atherosclerotic drug therapy. Finally, we provide an overview of the challenges and opportunities of applying these innovative nature-inspired nanocarriers. Oxford University Press 2023-08-11 /pmc/articles/PMC10460486/ /pubmed/37641591 http://dx.doi.org/10.1093/rb/rbad069 Text en © The Author(s) 2023. Published by Oxford University Press. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Ji, Weihong Zhang, Yuanxing Deng, Yuanru Li, Changyong Kankala, Ranjith Kumar Chen, Aizheng Nature-inspired nanocarriers for improving drug therapy of atherosclerosis |
title | Nature-inspired nanocarriers for improving drug therapy of atherosclerosis |
title_full | Nature-inspired nanocarriers for improving drug therapy of atherosclerosis |
title_fullStr | Nature-inspired nanocarriers for improving drug therapy of atherosclerosis |
title_full_unstemmed | Nature-inspired nanocarriers for improving drug therapy of atherosclerosis |
title_short | Nature-inspired nanocarriers for improving drug therapy of atherosclerosis |
title_sort | nature-inspired nanocarriers for improving drug therapy of atherosclerosis |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460486/ https://www.ncbi.nlm.nih.gov/pubmed/37641591 http://dx.doi.org/10.1093/rb/rbad069 |
work_keys_str_mv | AT jiweihong natureinspirednanocarriersforimprovingdrugtherapyofatherosclerosis AT zhangyuanxing natureinspirednanocarriersforimprovingdrugtherapyofatherosclerosis AT dengyuanru natureinspirednanocarriersforimprovingdrugtherapyofatherosclerosis AT lichangyong natureinspirednanocarriersforimprovingdrugtherapyofatherosclerosis AT kankalaranjithkumar natureinspirednanocarriersforimprovingdrugtherapyofatherosclerosis AT chenaizheng natureinspirednanocarriersforimprovingdrugtherapyofatherosclerosis |